Paul H Edelstein
15PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Sep 23, 2025
Structural and functional analysis of the Mycobacterium tuberculosis MmpS5L5 efflux pump presages increased bedaquiline resistance.Adam J Fountain, Jan Böhning, Stephen H McLaughlin
|Jul 16, 2025
Structural and functional analysis of the Mycobacterium tuberculosis MmpS5L5 efflux pump presages a pathway to increased bedaquiline resistance.Adam J Fountain, Jan Böhning, Stephen H McLaughlin
|Apr 17, 2025
Verapamil and its metabolite norverapamil inhibit the Mycobacterium tuberculosis MmpS5L5 efflux pump to increase bedaquiline activity.Adam J Fountain, Natalie J E Waller, Chen-Yi Cheung
|Apr 16, 2024
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute.Navaneeth Narayanan, Amy J Mathers, Eric Wenzler
|Nov 20, 2023
A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis.Chandrasekaran Padmapriyadarsini, John D Szumowski, Nabila Akbar
|Feb 10, 2023
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance.M Alexandra Lake, Kristin N Adams, Feilin Nie
Pageof 3
Frequent Collaborators
9 joint publications
Lalita Ramakrishnan
4 joint publications
Laura Whitworth
3 joint publications
Roger Sewell
2 joint publications
Ben F Luisi
2 joint publications
Nicholas M Moore
2 joint publications
Rodrigo E Mendes
2 joint publications
Eric Wenzler
2 joint publications
Christian G Giske
2 joint publications
Amy J Mathers
2 joint publications
Marcel A Behr
